MIG Capital Leads CHF 7.75 Million Seed Financing for ASTRA Therapeutics
Summary by Benzinga
2 Articles
2 Articles
MIG Capital leads CHF 7.75 million seed financing for ASTRA Therapeutics
MIG Capital, through its MIG Fonds, is investing 3 million Swiss Francs (CHF) in the Swiss start-up which designs precision drugs against eukaryotic pathogens. Digitalis Ventures co-leads the round with additional investment from Borealis Ventures, Kickfund and Venture Kick. Eukaryotic pathogens cause illness and death in animals, humans, and crops. MUNICH, Germany, and VILLIGEN, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- MIG Capital AG, one…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium